Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.73
25.04.24
-
25.04.25
2.28%
07:24

Risky Investment
Global_Player 
25.04.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-1.53%
07:24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.68
24.04.24
-
24.04.25
2.01%
26.04.24

Could be worthwhile Investment >10% per year
Vassago1 
24.04.24 50%
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.75
24.04.24
-
24.04.25
0.00%
26.04.24

Could be very worthwhile Investment >20% year
Vassago1 
24.04.24 50%
sell
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.96
24.04.24
-
24.04.25
40.30%
26.04.24

Could be worthwhile Investment >10% per year
Vassago1 
24.04.24 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.49
23.04.24
€3.00
23.04.25
-9.36%
01:00

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
skatcup 
23.04.24 80%
buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.70
19.04.24
-
19.04.25
26.17%
01:00

Very good company culture
Could be worthwhile Investment >10% per year
Few uniques
me8 
19.04.24 0%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.81
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 60%
sell
Delticom AG

Start price
Target price
Perf. (%)
€2.06
15.04.24
-
15.04.25
21.36%
01:00

High valuation
Probably not worthwhile Investment
Low dividend yield expected
negative Cash Flow expected
kostojunior 
15.04.24 0%
sell
Fair Value Reit-Ag

Start price
Target price
Perf. (%)
€3.66
15.04.24
-
15.04.25
2.73%
01:00

Medium risks for its business
negative Cash Flow expected
EBIT decline/stagnation expected
Increased challenges to pay loans and raise capital
kostojunior 
15.04.24 0%
buy
Alba SE

Start price
Target price
Perf. (%)
€10.50
15.04.24
€15.00
15.04.25
0.00%
01:00

Revenue growth >5% per year expected
Future proof or reliable business model
EBIT growth >5% per year expected
Top 10 in its market
kostojunior 
15.04.24 60%
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.54
15.04.24
-
15.04.25
-13.62%
01:00

Could be worthwhile Investment >10% per year
Normal challenges to pay loans and raise capital
EBIT growth >5% per year expected
High dividend yield expected
kostojunior 
15.04.24 60%
buy
Coupang Inc.

Start price
Target price
Perf. (%)
€20.35
15.04.24
€33.00
15.04.25
5.21%
01:00

positive Cash Flow expected
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
kostojunior 
15.04.24 80%
sell
B2gold Corp.

Start price
Target price
Perf. (%)
€2.74
15.04.24
-
15.04.25
-14.17%
25.04.24

Could be very worthwhile Investment >20% year
Below average Marketposition
Very high cyclical dependencies
Unknown brand
robertinio 
15.04.24 0%
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.50
14.04.24
€1.00
14.04.25
12.53%
17.04.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Traumtanz 
14.04.24 50%
buy
Globe Life Inc.

Start price
Target price
Perf. (%)
€55.50
14.04.24
-
14.04.25
27.93%
01:00

Could be worthwhile Investment >10% per year
melinda 
14.04.24 10%
buy
Informatica Inc.

Start price
Target price
Perf. (%)
€38.80
14.04.24
-
14.04.25
-23.20%
01:00

Could be worthwhile Investment >10% per year
melinda 
14.04.24 10%
buy
Q32 Bio Inc.

Start price
Target price
Perf. (%)
€14.94
13.04.24
-
13.04.25
-
01:00

Could be worthwhile Investment >10% per year
melinda 
13.04.24 10%
buy
Entera Bio

Start price
Target price
Perf. (%)
€2.32
13.04.24
-
13.04.25
-19.83%
01:00

Could be worthwhile Investment >10% per year
melinda 
13.04.24 10%
sell
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€13.78
13.04.24
€12.00
13.04.25
-15.09%
01:00

Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
nvestor 
13.04.24 50%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-6.54%
01:00

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-31.27%
01:00

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
nvestor 
13.04.24 50%
sell
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€22.07
13.04.24
€2.00
13.04.25
-5.48%
01:00

Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
nvestor 
13.04.24 50%
sell
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-9.27%
01:00

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
nvestor 
13.04.24 50%
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.97
13.04.24
€20.00
13.04.25
-14.53%
01:00

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
mixitrader 
13.04.24 50%